Skip to main content
Veracyte, Inc. (VCYT)
NASDAQ: VCYT · Real-Time Price · USD
33.37
-0.48 (-1.42%)
At close: Mar 9, 2026, 4:00 PM EDT
33.70
+0.33 (0.99%)
After-hours: Mar 9, 2026, 7:42 PM EDT

Veracyte Revenue

In the year 2025, Veracyte had annual revenue of $517.15M with 16.01% growth. Veracyte had revenue of $140.64M in the quarter ending December 31, 2025, with 18.55% growth.

Revenue (ttm)
$517.15M
Revenue Growth
+16.01%
P/S Ratio
5.13
Revenue / Employee
$684,960
Employees
755
Market Cap
2.65B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025517.15M71.38M16.01%
Dec 31, 2024445.76M84.71M23.46%
Dec 31, 2023361.05M64.52M21.76%
Dec 31, 2022296.54M77.02M35.09%
Dec 31, 2021219.51M102.03M86.85%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
ICON Public Limited Company 8.10B
RadNet 2.04B
Sotera Health Company 1.16B
Neogen 880.32M
NeoGenomics 727.33M
OPKO Health 606.88M
GeneDx Holdings 427.54M
Twist Bioscience 391.56M
Revenue Rankings

VCYT News

More News